Covid-19: India approves further trials for first homegrown mRNA shot
BENGALURU (India), Aug 25 (NNN-AGENCIES) — India has approved further clinical trials for its first homegrown mRNA-based COVID-19 vaccine developed by Gennova Biopharmaceuticals, the government said, after the shot was found to be safe and effective in an early-stage study. Gennova is among a few pharmaceutical firms worldwide, including Moderna…

